CYP21A2 and polycystic ovary syndrome: All 46 samples from the unrelated patients with hyperandrogenemia were further re-analyzed using the commercial real-time PCR CAH Real Fast CNV Assay (Vienna Lab) so as to re-confirm the presence or absence of the duplicated CYP21A2 genes obtained by MLPA.